As we commemorate the fifth anniversary of the Institute for Gene Therapies (IGT) today, I want to take a look back at the strides we've...

IGT leaders recently penned a piece exploring the strides being made in gene therapy and highlighting the ongoing challenges that must be...

As Newborn Screening Awareness Month concludes, IGT applauds the tireless work of advocates who dedicate themselves 365 days of the year...

Author: Andrea Matthews, Founder, Children’s Sickle Cell Foundation, Inc.   Newborn screening (NBS) is an important public health measure...

Newborn screening is critical to ensure faster access to treatment and cures for genetic conditions. This September, IGT is recognizing...

On Friday, June 28, the House Budget Committee Health Care Task Force hosted a roundtable entitled, “Paying for 21st Century Cures:...

The Centers for Medicare and Medicaid Services (CMS) may soon finalize proposed changes to the Medicaid Drug Rebate Program (MDRP) that,...

On May 9, the Institute for Gene Therapy (IGT), along with the Alliance for Regenerative Medicine (ARM), held a Congressional briefing...

Today, Senators Markwayne Mullin (R-OK), Kyrsten Sinema (AZ), Tim Scott (SC), and Maggie Hassan (NH) introduced the Senate companion to...

By Regina Hartfield, President and CEO, Sickle Cell Disease Association of America, Inc. This year, we celebrate a landmark step forward...